--- title: API Synthesis & Manufacturing CDMOs in Asia-Pacific path: /services/api-synthesis/apac companies_count: 38 --- # API Synthesis & Manufacturing CDMOs in Asia-Pacific 38 published CDMOs match API Synthesis & Manufacturing in Asia-Pacific. Locations in this set include India, United States, China, Switzerland, United Kingdom, and France. Capabilities that show up most often in this set: Small Molecule, Peptide, Biologics (Other), Antibody-Drug Conjugate (ADC), and Biologics (Monoclonal Antibodies). ## Matching companies - [Akums Drugs and Pharmaceuticals Ltd.](/companies/akums) - India's largest CDMO with 15+ state-of-the-art facilities and 30% domestic market share, manufacturing 4,100+ formulations across tablets, capsules, injectables, APIs, and specialty dosage forms under WHO-GMP, USFDA, EU-GMP, and TGA compliance. - [Almac Group](/companies/almacgroup) - Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities. - [Amneal Pharmaceuticals](/companies/amneal-pharmaceutical) - U.S.-based biopharmaceutical company offering oral solid dosage, injectables, and API manufacturing with FDA-approved facilities across the U.S. and India, including advanced capabilities in lyophilization, aseptic processing, and oncology formulations. - [Aurobindo Pharma CDMO](/companies/aurobindo) - Aurobindo Pharma Limited is one of the largest generic pharmaceutical companies globally, with a strong commitment to making medicines affordable and accessible. - [Axplora](/companies/axplora) - Global CDMO and API manufacturer specializing in complex small molecule development, ADC manufacturing, HPAPIs, and hazardous chemistry across ten production sites in Europe, India, and the US. - [Bachem](/companies/bachem) - Global leader in peptide and oligonucleotide development and manufacturing, offering GMP-compliant clinical and commercial supply from early research through commercial scale. - [Biocon](/companies/biocon) - Fully integrated biopharmaceutical company developing affordable biosimilars, generic formulations, and complex APIs for diabetes, cancer, and autoimmune diseases. - [Carbogen Amcis](/companies/carbogen-amcis) - Full-service CDMO offering integrated drug substance and sterile drug product development and manufacturing from early phase through commercialization, with specialized capabilities in API synthesis, process development, analytical services, and stability testing across multiple scales. - [Catalent](/companies/catalent) - Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply. - [Charles River Laboratories](/companies/criver) - Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years. - [Clearsynth](/companies/clearsynth) - Clearsynth delivers advanced deuterium science, isotopically labelled compounds, custom synthesis, and specialized CDMO services for small-molecule drug discovery and development. ISO 17025, ISO 17034, and ISO 9001:2015 certified with capabilities spanning reference standards, generic APIs, process development, and scale-up manufacturing. - [Curia](/companies/curiaglobal) - Global CDMO with 30+ years of experience offering integrated services across small molecule, generic APIs, sterile drug product, and biologics manufacturing, backed by 20+ facilities and 3,000+ professionals across North America, Europe, and India. - [DSK InnoSciences Ltd](/companies/dskinnosciences) - DSK InnoSciences is an established contract chemistry services company in Bangalore, India, offering synthesis, process development, and manufacturing of pharmaceuticals, specialty chemicals, and peptides from milligram to kilogram scale. - [Dipharma](/companies/dipharma) - Global CDMO and API manufacturer with 600 employees, 4 cGMP plants, and 75+ years of experience in hazardous chemical synthesis, offering exclusive synthesis services and catalogue APIs with FDA, AIFA, and PMDA inspections since 1970. - [Divi's Laboratories](/companies/divislabs) - World's largest API manufacturer and trusted CDMO partner for 25+ years, offering generic APIs, custom synthesis, peptides, and nutraceutical ingredients to 100+ countries with complete backward integration and green chemistry principles. - [Dr. Reddy's Laboratories](/companies/drreddys) - Integrated global pharmaceutical company manufacturing generics, APIs, biosimilars, and innovative medicines across 66 countries with capabilities in small molecule and biologics development and manufacturing. - [Flamma](/companies/flammagroup) - Privately held small molecule CDMO with FDA-inspected cGMP facilities in Italy, USA, and China, offering custom manufacturing, development, and specialized technologies including HPAPI, continuous flow, and cryogenic API synthesis from early-stage to commercial scale. - [Gland Pharma Limited](/companies/gland-pharma) - Gland Pharma is a vertically integrated CDMO offering sterile injectable manufacturing across vials, lyophilized, prefilled syringes, and ophthalmic formats, with four cGMP-compliant formulation facilities and four API manufacturing units, supported by R&D capabilities in formulation, analytical, and process development. - [Global Biotech Laboratories](/companies/globalbiotechlaboratories) - Global Biotech Laboratories is a peptide and oligonucleotide CDMO offering end-to-end contract development and manufacturing from route scouting through validated commercial supply, with cGMP and ICH Q7 compliance across manufacturing sites on three continents. - [Hikal](/companies/hikal) - Hikal is a contract development and manufacturing partner for pharmaceuticals, biotech, and specialty chemicals, offering API synthesis, process development, and custom manufacturing at FDA-approved facilities across five Indian manufacturing sites.